Veratramine influences the proliferation of human osteosarcoma cells through modulating the PI3K/AKT signaling cascade
Open Access
- 1 January 2026
- journal article
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (1) , 101630
Abstract
Osteosarcoma (OS) is a highly aggressive tumor with a propensity for early metastasis. Current treatment methods, such as chemotherapy, often bring significant side effects, affecting patients' quality of life. Veratramine (VER), an alkaloid derived from the American lily plant, has shown potential in cancer treatment. This study looks at the effects and mechanisms of VER on osteosarcoma. VER's impact was assessed using a variety of procedures, including crystal violet staining, the CCK-8 assay, and the colony formation assay, which measured cell proliferation. Wound healing assay and transwell assay were employed to evaluate the migration and invasion of osteosarcoma cells. Hoechst33258 staining, flow cytometry, and transmission electron microscopy were used to investigate apoptosis. Protein expression was assessed using western blotting and immunofluorescence. Blood tests and hematoxylin-eosin staining were used to establish VER's in vivo safety, and its effectiveness was proven using an orthotopic tumor model. The results showed that VER greatly decreased osteosarcoma cell growth, migration, and invasion while inducing apoptosis. Animal tests confirmed these findings, confirming VER's high efficacy and safety in vivo. VER might function by inhibiting the PI3K/AKT signaling pathway. To sum up, VER shows promise in treating osteosarcoma by exhibiting significant anti-tumor activity in laboratory and animal studies, likely through the regulation of the PI3K/AKT signaling pathway.Keywords
Funding Information
- Chongqing Medical University (cyyy-xkdfjhcgzh-202303)
- Natural Science Foundation of Chongqing Municipality (CSTB2024NSCQ-MSX1218)
- China Postdoctoral Science Foundation (2024MD754029)
This publication has 52 references indexed in Scilit:
- Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancerCancer Cell, 2024
- Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studiesMedcomm, 2023
- MetastasisCell, 2023
- Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughsCancer Letters, 2021
- Cardamonin inhibits the growth of human osteosarcoma cells through activating P38 and JNK signaling pathwayBiomedicine & Pharmacotherapy, 2021
- PI3K/Akt signaling in osteosarcomaClinica Chimica Acta, 2015
- Andrographolide inhibits TNFα-induced ICAM-1 expression via suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and PI3K/Akt/AP-1 pathways in human endothelial cellsBiochemical Pharmacology, 2014
- Antitumor and antiplatelet activity of alkaloids from veratrum dahuricumPhytotherapy Research, 2010
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Cell cycle effects of gemcitabineInternational Journal of Cancer, 2001